U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): December 20, 2010
|
NUTRA
PHARMA CORP.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
California
|
000-32141
|
91-2021600
|
|
(State
or jurisdiction of
|
(Commission
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
File
Number)
|
Identification
No.)
|
|
2776
University Drive
|
|
Coral
Springs, Florida 33065
|
|
(Address
of principal executive offices) (Zip
Code)
|
|
Registrant's
telephone number: 954-509-0911
|
(Former
name or former address, if changed since last report)
Nutra
Pharma Corp. is referred to herein as “we,” “our,” or “us”.
Section
1 – Registrant’s Business and Operations
Item
5.02. Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers
Resignation
of David Isserman
On
December 20, 2010, David Isserman resigned as our Chief Marketing Officer
effective as of December 20, 2010.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
December 21, 2010.
Nutra
Pharma Corp.
/s/ Rik
Deitsch
By: Rik
Deitsch, Chief Executive Officer